Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Frontiers in Immunology|February 2, 2018
Lactococcus lactis As a Versatile Vehicle for Tolerogenic ImmunotherapyDana P Cook, Conny Gysemans, Chantal MathieuDiabetologia|October 30, 2019
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetesGiuliana Ventriglia, Francesca Mancarella, Guido Sebastiani, et al.Plos One|November 3, 2017
MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onsetHannelie Korf, Laura Breser, Jelter Van Hoeck, et al.Diabetes|November 18, 2020
Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD MiceFernanda M C Sodré, Samal Bissenova, Ylke Bruggeman, et al.Neurobiology of Disease|December 4, 2017
Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growthLawrence Van Helleputte, Mandy Kater, Dana P Cook, et al.Frontiers in Immunology|June 26, 2020
Intestinal Delivery of Proinsulin and IL-10 via Lactococcus lactis Combined With Low-Dose Anti-CD3 Restores Tolerance Outside the Window of Acute Type 1 Diabetes DiagnosisDana P Cook, João Paulo Monteiro Carvalho Mori Cunha, Pieter-Jan Martens, et al.Diabetes|October 24, 2018
Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 DiabetesMijke Buitinga, Aïsha Callebaut, Fernanda Marques Câmara Sodré, et al.Pageof 1